Junping Shi

机构：Peking University, Affiliated Hospital of Hangzhou Normal University, Peking University People's Hospital, Peking University Third Hospital · ORCID：0000-0001-9434-897X

发表论文 260 篇 · 总被引 5239 次 · h-index 37

代表论文

• Anthropometric Measures and Mortality Risk in Individuals With Metabolic Dysfunction‐Associated Steatotic Liver Disease ( MASLD ): A Population‐Based Cohort Study (2025 · Alimentary Pharmacology & Therapeutics · 被引 22)
• Cardiovascular-kidney-metabolic (CKM) syndrome is associated with increased mortality in individuals with metabolic dysfunction-associated steatotic liver disease (MASLD) (2025 · Communications Medicine · 被引 12)
• Chiglitazar in MASLD with hypertriglyceridemia and insulin resistance: A phase II, randomized, double-blind, placebo-controlled study (2025 · Hepatology · 被引 10)
• Application of machine learning and deep learning in metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis (2025 · Journal of Advanced Research · 被引 9)
• Relationship between liver fat, pancreatic fat, and new-onset type 2 diabetes mellitus in patients with metabolic dysfunction-associated fatty liver disease (2025 · Acta Diabetologica · 被引 8)
• NFATc1 facilitates hepatocellular carcinoma progression by regulating the senescence-associated secretory phenotype (2025 · Scientific Reports · 被引 5)